Nephrology
Pseudohypoaldosteronism Panel
Overview
Test Name
Test Code
Test Category
Test Subcategory
Disease(s) Targeted
Who Is The Test For?
Test Approach
Whole exome sequencing (WES) with in silico gene panel analysis.
No. of Genes
Panel Content
Deliverables
Clinical Report (Download a sample report here)
Turnaround Time
~3-6 weeks*
Specimen Requirements
For detailed information about the sample requirements, please consult our clinical sample requirements page.
About Pseudohypoaldosteronism
Pseudohypoaldosteronism (PHA) is a rare disorder where the body does not respond to the hormone aldosterone, leading to electrolyte imbalances like high potassium and low sodium, which impact the blood pressure. It is divided into two main types inherited in both autosomal dominant and autosomal recessive manners: Type I, which is caused by variants in genes that encode sodium channels subunits (SCNN1A, SCNN1G or SCNN1B) or aldosterone receptor (NR3C2) and Type II, which is caused by variants in the CUL3, KLHL3, WNK1 and WNK4 genes.
Gene Panel Workflow
Order a test using our clinical portal
Preview Documents